Science Explorer Interactive view Map
Company · Grenzach-Wyhlen · Germany

Roche Pharma AG (Germany)

In research, Roche Pharma AG (Germany) stands highest in Life Sciences (#3,641 of 7,800 worldwide), Medicine (#7,009 of 10,443 worldwide) and Health Sciences (#8,818 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Molecular Biology — Molecular Biology is 7.2× its share of world research.

World rank, 2022–2025
#8,387
of 28,054 · #7,762 all time
Rank in Germany
#338
of 1,178
Research works
925
▲ 17% vs 2013–17
Citations
35k
37.4 per fractional work
Top-10% rate
22.3%
record average 16.5%
Open access
45%
world 28%

What is Roche Pharma AG (Germany) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Life SciencesDomain #3,641 of 7,800 22.7%62 #3083
MedicineField #7,009 of 10,443 24.8%66 #5295
Health SciencesDomain #8,818 of 11,982 24.3%68 #7181

Each strip is that field’s whole ranked pool, with the notch where Roche Pharma AG (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Life Sciences#3,083 #3,641
  2. Medicine#5,295 #7,009
  3. Health Sciences#7,181 #8,818
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Roche Pharma AG (Germany) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 7.2× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 33.4 works7.2×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.41× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.20× its world share, 42 worksBiochemistry, Geneti…Immunology and Microbiology: 6.64× its world share, 10 worksImmunology and Micro…Neuroscience: 1.94× its world share, 5 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.75× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 0.52× its world share, 0 worksChemical EngineeringChemistry: 1.75× its world share, 4 worksChemistryComputer Science: 0.15× its world share, 2 worksComputer ScienceEnergy: 0.39× its world share, 1 worksEnergyEngineering: 0.34× its world share, 8 worksEngineeringEnvironmental Science: 0.09× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.10× its world share, 1 worksMaterials ScienceMathematics: 1.60× its world share, 3 worksMathematicsPhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyDentistry: 0.03× its world share, 0 worksDentistryHealth Professions: 0.21× its world share, 1 worksHealth ProfessionsMedicine: 2.25× its world share, 66 worksMedicineNursing: 0.05× its world share, 0 worksNursingVeterinary: 4.79× its world share, 1 worksVeterinaryBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Decision Sciences: 0.99× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 0.37× its world share, 1 worksEconomics, Econometr…Psychology: 0.07× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 6.6×. Every wedge is a field page.

Who are the top researchers at Roche Pharma AG (Germany)?

Ranked on the composite score, Wolfgang Petrich, Roland F. Staack and Ulrich Brinkmann lead among researchers whose main affiliation is Roche Pharma AG (Germany).

  1. 1 Wolfgang Petrich Germany · #278,653 worldwide 113 citations · 20 works
  2. 2 Roland F. Staack Germany · #499,837 worldwide 68 citations · 18 works
  3. 3 Ulrich Brinkmann Germany · #581,327 worldwide 90 citations · 36 works
  4. 4 Guy Georges Germany · #984,342 worldwide 50 citations · 16 works
  5. 5 Ulrich H. Weidle Germany · #1,247,733 worldwide 35 citations · 16 works
All ranked researchers at Roche Pharma AG (Germany)

Which keywords describe research at Roche Pharma AG (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Biopharmaceuticals, Immunogenicity, Antibody Engineering, Fc Receptors and Recombinant Proteins.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Monoclonal Antibodies24▲ 173×3 topics
  2. Therapeutic Antibodies21▲ 193×2 topics
  3. Glycosylation20▲ 116×3 topics
  4. Biopharmaceuticals12▲ 159×3 topics
  5. Immunogenicity12▲ 184×2 topics
  6. Antibody Engineering12▲ 139×1 topic
  7. Fc Receptors12▲ 139×1 topic
  8. Biomarkers9▲ 8.9×12 topics
  9. Recombinant Proteins9▲ 196×2 topics
  10. Stability9▲ 26×2 topics
  11. Chromatography9▲ 392×1 topic
  12. Protein Aggregation9▲ 112×1 topic
  13. Cancer9▲ 4.2×21 topics
  14. Cancer Immunotherapy7▲ 28×2 topics
  15. Neurodegeneration6▲ 14×6 topics
  16. Monoclonal Antibody6▲ 74×2 topics
  17. Neuroinflammation6▲ 14×5 topics
  18. Cell Culture6▲ 34×2 topics
  19. Immunotherapy6▲ 5.3×9 topics
  20. Regulation6▲ 6.8×6 topics
  21. Mammalian Cells6▲ 150×1 topic
  22. Recombinant Protein6▲ 150×1 topic
  23. Innate Immunity5▲ 10×6 topics
  24. Lymphoma5▲ 19×2 topics
  25. Tumor Regression5▲ 28×2 topics
  26. Alzheimer's Disease4▲ 10×5 topics
  27. Mass Spectrometry4▲ 19×4 topics
  28. Therapeutics4▲ 27×2 topics
  29. CAR T Cells4▲ 39×1 topic
  30. Chimeric Antigen Receptor4▲ 39×1 topic
  31. Therapeutic Strategies4▲ 30×2 topics
  32. Biogenesis4▲ 16×2 topics
  33. Immunity4▲ 6.9×5 topics
  34. Neuroimaging4▲ 10×4 topics
  35. Amyloid Hypothesis4▲ 46×1 topic
  36. Immune System4▲ 11×4 topics
  37. Tau Pathology4▲ 46×1 topic
  38. Cognitive Training4▲ 28×2 topics
  39. Dementia4▲ 27×1 topic
  40. Mild Cognitive Impairment4▲ 30×1 topic

Which research topics does Roche Pharma AG (Germany) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, Viral Infectious Diseases and Gene Expression in Insects and CAR-T cell therapy research.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 12 works
  2. 2 Protein purification and stability Molecular Biology 9 works
  3. 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 6 works
  4. 4 CAR-T cell therapy research Oncology 4 works
  5. 5 Alzheimer's disease research and treatments Physiology 4 works
  6. 6 Dementia and Cognitive Impairment Research Psychiatry and Mental health 4 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 3 works
  8. 8 Glycosylation and Glycoproteins Research Molecular Biology 3 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 2 works
  10. 10 Circular RNAs in diseases Molecular Biology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.0%not open55.0%

World: 28% of research is openly available.

with international co-authors51.9%domestic only48.1%

World: 19% is written across borders.

How has Roche Pharma AG (Germany)'s research output changed?

Output in 2018–2022 was 17% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Grenzach-Wyhlen

All research institutions in Grenzach-Wyhlen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.